Constitutive Cholesterol-dependent Endocytosis of Melanocortin-4 Receptor (MC4R) is Essential to Maintain Receptor Responsiveness to α-melanocyte-stimulating Hormone (α-MSH)
Overview
Authors
Affiliations
Melanocortin-4 receptor (MC4R) is a G-protein-coupled receptor expressed in the hypothalamus where it controls feeding behavior. MC4R cycles constitutively and is internalized at the same rate in the presence or absence of stimulation by the agonist, melanocyte-stimulating hormone (α-MSH). This is different from other G-protein-coupled receptors, such as β(2)-adrenergic receptor (β(2)AR), which internalizes more rapidly in response to agonist stimulation. Here, it is found that in immortalized neuronal Neuro2A cells expressing exogenous receptors, constitutive endocytosis of MC4R and agonist-dependent internalization of β(2)AR were equally sensitive to clathrin depletion. Inhibition of MC4R endocytosis by clathrin depletion decreased the number of receptors at the cell surface that were responsive to the agonist, α-MSH, by 75%. Mild membrane cholesterol depletion also inhibited constitutive endocytosis of MC4R by ∼5-fold, while not affecting recycling of MC4R or agonist-dependent internalization of β(2)AR. Reduced cholesterol did not change the MC4R dose-response curve to α-MSH, but it decreased the amount of cAMP generated per receptor number indicating that a population of MC4R at the cell surface becomes nonfunctional. The loss of MC4R function increased over time (25-50%) and was partially reversed by mutations at putative phosphorylation sites (T312A and S329A). This was reproduced in hypothalamic GT1-7 cells expressing endogenous MC4R. The data indicate that constitutive endocytosis of MC4R is clathrin- and cholesterol-dependent. MC4R endocytosis is required to maintain MC4R responsiveness to α-MSH by constantly eliminating from the plasma membrane a pool of receptors modified at Thr-312 and Ser-329 that have to be cycled to the endosomal compartment to regain function.
Identification of serum metabolic traits of AIWG in first-episode schizophrenia patients.
Zhang S, Zhai Z, Gao T, Kuai X, Li X, Dong Y BMC Psychiatry. 2024; 24(1):946.
PMID: 39716136 PMC: 11667919. DOI: 10.1186/s12888-024-06413-8.
Griffin H, Hanson J, Phelan K, Baldini G Cells. 2024; 13(15.
PMID: 39120267 PMC: 11311852. DOI: 10.3390/cells13151235.
Botha R, Kumar S, Grimsey N, Mountjoy K J Mol Endocrinol. 2023; 71(1).
PMID: 37040537 PMC: 10304906. DOI: 10.1530/JME-23-0008.
Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis.
Chattopadhyay A, Sharma A Front Mol Biosci. 2023; 10:1120373.
PMID: 36714259 PMC: 9878332. DOI: 10.3389/fmolb.2023.1120373.
Cholesterol-dependent endocytosis of GPCRs: implications in pathophysiology and therapeutics.
Kumar G, Chattopadhyay A Biophys Rev. 2022; 13(6):1007-1017.
PMID: 35059024 PMC: 8724494. DOI: 10.1007/s12551-021-00878-7.